| Financial Year |
March 31 2023 |
| Monetary Funds |
21,827,943,590.45 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
3,617,817,056.17 |
| Advances to Suppliers |
470,503,174.44 |
| Other Receivables |
135,972,954.54 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
478,936,333.98 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
757,792,391.69 |
| Other Current Assets |
123,891,941.04 |
| Total Current Assets |
28,445,885,442.31 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,045,350,029.67 |
| Long-term Equity Investment |
1,783,052,431.31 |
| Investment Properties |
244,286.61 |
| Fixed Assetes |
33,905,575,869.21 |
| Under-construction Projects |
5,250,427,785.42 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
9,166,610,229.57 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,995,220.56 |
| Deferred Income Tax Assets |
244,567,943.45 |
| Other Non-Current Assets |
321,193,246.87 |
| Sub-Total of Non-Current Assets |
53,824,542,167.80 |
| Total Assets |
82,270,427,610.11 |
| Short-Term Loans |
6,644,170,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
13,683,072,258.64 |
| Accounts Payable |
4,380,031,911.03 |
| Accounts Received In Advance |
10,020,873.99 |
| Employee Compensation Payable |
1,289,049,280.26 |
| Taxes Payable |
643,160,679.38 |
| Interest Payable |
-- |
| Dividend Payable |
27,456,855.37 |
| Other payables |
1,495,266,338.66 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
7,446,314,117.68 |
| Other Current Liabilities |
198,965,818.13 |
| Sub-Total of Current Liabilities |
37,325,678,609.57 |
| Long-term Loans |
1,920,000,000.00 |
| Bonds Payable |
7,232,669,792.17 |
| Long-Term Accounts Payable |
5,591,801,359.16 |
| Special Payable |
-- |
| Estimatied Liabilities |
2,023,392,440.72 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
17,396,058,182.25 |
| Total Liabilities |
54,721,736,791.82 |
| Paid-In Capital(Or Share Stock) |
2,315,215,955.00 |
| Capital Surplus |
3,200,469,043.35 |
| Surplus Reserve |
2,655,559,595.02 |
| LESS:Treasury Stock |
64,908,340.00 |
| Undistributed Profits |
13,704,746,989.54 |
| Minority Stockholder's Interest |
3,216,084,829.72 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
24,332,605,988.57 |
| Owner's Equity（Stockholder's Equity） |
27,548,690,818.29 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
82,270,427,610.11 |
